The BMT Leadership team reviewed potential causes: Forty new staff hired; census and acuity were higher; Travelers and float staff were utilized. A process was needed to ensure TAC/CSA levels were reliable and bedside caregivers had appropriate knowledge to manage TAC/CSA infusions and samplings.
Intervention: Immediate efforts focused on nursing staff re-education.
- Upon admission, nursing to designate a lumen for TAC/CSA infusion
- No TAC/CSA sampling will be drawn from designated lumen.
- TAC/CSA infusion is primary line infusing into dedicated port.
- TAC/CSA infusion turned off 10 minutes prior to level sampling.
The unit-based council led this initiative. They recommended alerts to the special nature of these drugs. While under review, another contamination occurred. Additional recommendations made:
- BMT Float guidelines reviewed -TAC/CSA process added
- TAC/CSA process included in traveler orientation
- RN Resource assigned to new hires, floats, and travelers
- TAC/CSA education poster displayed on BMT units
In February 2012, another contamination was noted. The BMT Leadership team and unit-based council convened to review additional opportunities.
- Mandatory Healthstream education developed. Healthstream is an electronic education system which includes documentation of compliance.
- Clamp unused lumens during sampling process.
- Interdisciplinary collaboration to create a pop up screen when medication is scanned-”Infuse in designated lumen ONLY. For help, see your charge nurse.”
Results: Significant reduction in lumen contamination; enhanced patient satisfaction. No contaminations since February 2012.
Discussion: Ongoing review and process improvements needed. In 2013 - mandatory review of TAC/CSA process in skills lab; new TAC/CSA competency required for all BMT staff within 3 months of hire.
See more of: Transplant Nursing Conference